Cosaldon for vascular disorders?
D000328:Adult; D000368:Aged; D000818:Animals; D002415:Cats; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002825:Chorioretinitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D051379:Mice; D008875:Middle Aged; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D011817:Rabbits; D014652:Vascular Diseases / Q000188:drug therapy*; D014970:Xanthines / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D009539:Nicotinic Acids; D014970:Xanthines